
P/E Ratio: Price to Earnings - Most used valuation metric
Analyzing Investment Quality
Processing 9 key metrics...
Loading shareholding data...
| Insider Name | Transaction Date | Filing Date | Total Shares | Change | Price | Action |
|---|---|---|---|---|---|---|
SARANSH MUNDRA | 10 Jan 2025 | 13 Jan 2025 | 11,874 | 4,500 | ₹295 | BUY |
Deval Prakash Majmudar | 09 Jan 2025 | 13 Jan 2025 | 3.67 L | 84,000 | ₹54.91 | BUY |
SOUVIK SANJOY SHYAM | 09 Jan 2025 | 13 Jan 2025 | 15,600 | 10,000 | ₹52.5 | BUY |
SRINIVASAN MADABUSHI | 18 Jan 2025 | 21 Jan 2025 | 42,000 | 42,000 | ₹330.6 | BUY |
PETER LIMERI | 18 Jan 2025 | 21 Jan 2025 | 1.14 L | 1.14 L | ₹295 | BUY |
REKHA TIMBLO | 10 Feb 2025 | 18 Feb 2025 | 2,500 | 2,500 | ₹1,696.82 | BUY |
Dinesh Rijhwani | 25 Feb 2025 | 28 Feb 2025 | 9,159 | 641 | ₹1,907.05 | SELL |
Dinesh Rijhwani | 24 Feb 2025 | 28 Feb 2025 | 9,800 | 200 | ₹1,825 | SELL |
Arindrajit Datta | 05 Mar 2025 | 06 Mar 2025 | 2.88 L | 7,000 | ₹1,773.05 | SELL |
Arindrajit Datta | 04 Mar 2025 | 06 Mar 2025 | 2.95 L | 5,000 | ₹1,799.49 | SELL |
Arindrajit Datta | 03 Mar 2025 | 06 Mar 2025 | 3.00 L | 19,541 | ₹1,776.28 | SELL |
Arindrajit Datta | 06 Mar 2025 | 10 Mar 2025 | 2.83 L | 5,000 | ₹1,803.13 | SELL |
ABHAY KUMAR SRIVASTAVA | 10 Mar 2025 | 18 Mar 2025 | 53,703 | 1,297 | ₹1,730.03 | SELL |
Dinesh Rijhwani | 25 Mar 2025 | 25 Mar 2025 | 10,850 | 2,000 | ₹824.22 | BUY |
Dinesh Rijhwani | 05 Mar 2025 | 25 Mar 2025 | 8,850 | 150 | ₹1,800 | SELL |
Dinesh Rijhwani | 04 Mar 2025 | 25 Mar 2025 | 9,000 | 159 | ₹1,800 | SELL |
Dinesh Rijhwani | 26 May 2025 | 27 May 2025 | 14,660 | 1,000 | ₹1,595 | SELL |
Dinesh Rijhwani | 23 May 2025 | 27 May 2025 | 15,660 | 840 | ₹1,586.43 | SELL |
Dinesh Rijhwani | 21 May 2025 | 27 May 2025 | 16,500 | 350 | ₹1,580 | SELL |
Dinesh Rijhwani | 09 May 2025 | 27 May 2025 | 16,850 | 6,000 | ₹75 | BUY |
Ajay Madatiparambil | 05 Jun 2025 | 06 Jun 2025 | 1.22 L | 20,000 | ₹1,594.62 | SELL |
Ajay Madatiparambil | 04 Jun 2025 | 06 Jun 2025 | 1.42 L | 10,000 | ₹1,525 | SELL |
Dinesh Rijhwani | 04 Jun 2025 | 06 Jun 2025 | 12,000 | 2,350 | ₹1,585.75 | SELL |
Dinesh Rijhwani | 27 May 2025 | 06 Jun 2025 | 14,350 | 150 | ₹1,595.3 | SELL |
Dinesh Rijhwani | 27 May 2025 | 06 Jun 2025 | 14,500 | 160 | ₹1,595.3 | SELL |
Mitul Thakker | 09 Jun 2025 | 11 Jun 2025 | 3.29 L | 46,000 | ₹1,625 | SELL |
Katherine Davis | 09 Jun 2025 | 11 Jun 2025 | 2.48 L | 10,600 | ₹1,677.46 | SELL |
Mitul Thakker | 27 May 2025 | 11 Jun 2025 | 3.75 L | 10 | ₹160 | SELL |
Ajay Madatiparambil | 13 Jun 2025 | 16 Jun 2025 | 1.05 L | 10,000 | ₹1,705.84 | SELL |
Ajay Madatiparambil | 12 Jun 2025 | 16 Jun 2025 | 1.15 L | 7,500 | ₹1,717.46 | SELL |
Standard pivot points - most widely used
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹1567.07 | +₹193.17 | +14.06% |
| R3 | ₹1489.27 | +₹115.37 | +8.40% |
| R2 | ₹1449.03 | +₹75.13 | +5.47% |
| R1 | ₹1411.47 | +₹37.57 | +2.73% |
| PIVOT | ₹1371.23 | -2.67 | -0.19% |
| CURRENT | ₹1373.90 | - | - |
| S1 | ₹1178.07 | -₹195.83 | -14.25% |
| S2 | ₹1255.87 | -₹118.03 | -8.59% |
| S3 | ₹1293.43 | -₹80.47 | -5.86% |
| S4 | ₹1333.67 | -₹40.23 | -2.93% |
is trading CPR, indicating
CPR is
Day's range: ~
Trading Inside opening range
No peer comparison data available

Inventurus Knowledge Solutions Limited (IKS) is a technology company specializing in providing healthcare solutions with a focus on improving efficiency and effectiveness within physician enterprises. Their core business revolves around a proprietary care enablement platform designed to support both outpatient and inpatient care activities.
This platform is deployed to assist various types of healthcare organizations in streamlining their operations. The clientele served includes a wide range of entities, encompassing large health systems, academic medical centers, and multi-specialty and single-specialty medical groups. Beyond these, IKS also caters to ancillary healthcare organizations and other outpatient healthcare delivery organizations. This broad client base demonstrates the platform's adaptability and relevance across different healthcare settings.
IKS's geographical reach extends across North America and Australia, indicating a significant international presence within the healthcare technology market. The company's operations in the United States, Canada, and Australia showcase its success in penetrating key healthcare markets with a demonstrated demand for efficient and effective care enablement technology. The services offered through their platform are aimed at enhancing various aspects of patient care delivery within these healthcare organizations.
Founded in 2006 and headquartered in Navi Mumbai, India, IKS has established itself as a notable player in the global healthcare technology sector. Its continued success hinges on the ongoing development and refinement of its care enablement platform to meet the evolving needs of the healthcare industry. The company leverages its technological expertise and operational capabilities to offer solutions that ultimately aim to improve patient care while enhancing the efficiency and productivity of healthcare providers.
801, Building No. 5&6, 8th Floor,, Mindspace Business Park (SEZ), Thane-Belapur Road, Airoli
Navi Mumbai
MAHARASHTRA
IN
Tel: 912239643205
Website:https://www.ikshealth.com/
Group: Health Care Equipment & Services
Sector: Health Care
Industry: Health Care Technology
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 7,530
IPO Date: 19/12/2024
Mr. Berjis Desai
Non-Executive Chairman of the Board
Mr. Sachin Gupta
Chief Executive Officer, Whole Time Director
Ms. Nithya Balasubramanian
Chief Financial Officer
Mr. Sameer Chavan
Compliance Officer, Company Secretary
Mr. Joseph Benardello
Additional Non-Executive Director
Mr. Amit Goela
Non-Executive Nominee Director
Mr. Utpal Sheth
Non-Executive Nominee Director
Dr. Keith Jones
Independent Director
Mr. Clarence King
Independent Director
Dr. Mary Klotman
Independent Director
Get answers to the most common questions about Inventurus Knowledge Solutions Ltd stock price, fundamentals, financial metrics, and investment analysis